Brief: Waverley Pharma Announces Signing Of Term Sheet
08/09/2020 18:15
Sept 8 (Reuters) - Waverley Pharma Inc WAVE.V :
* WAVERLEY PHARMA ANNOUNCES SIGNING OF TERM SHEET TO ACQUIRE
EXCLUSIVE RIGHTS TO MARKET SIX GENERIC ONCOLOGY PRODUCTS IN THE
UNITED STATES
Source text for Eikon: ID:nCNWsCbgka
Further company coverage: WAVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England